ID   HAP1 RPS6KA4 (-) RPS6KA5 (-) 1
AC   CVCL_DX53
SY   HZGHC006960c001; Double knockout cell line RPS6KA4 1bp insertion in exon 4 and RPS6KA5 19bp deletion in exon 3
DR   Horizon_Discovery; HZGHC006960c001
CC   Group: Haploid karyotype cell line.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 10433; RPS6KA4.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; 10434; RPS6KA5.
CC   Sequence variation: Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_TJ66 ! HAP1 RPS6KA5 (-) 1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 30-01-24; Last updated: 02-05-24; Version: 2
//